Conclusions: In patients with suspected PAOD undergoing IA-DSA, the incidence of CI-AKI at 24 hours following contrast administration was significantly less for patients who received iodixanol compared with various LOCM; this difference was primarily driven by iopamidol.
PMID: 20540038 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)